An Diagnostic Cohort on AQP4-Immunoglobulin G Detection Kit
An Diagnostic Cohort on Applicability and Accuracy of AQP4-Immunoglobulin G Detection Kit in the Diagnosis of Neuromyelitis Optica Spectrum Disorders
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Guangzhou, China
- Third Affiliated Hospital of Sun Yat-sen University
-
-
Fujian
-
Fuzhou, Fujian, China, 350005
- Department of Neurology,First Affiliated Hospital of Fujian Medical University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patients who were diagnosed with NMOSD , and the cell-based assay was used to determine the AQP4-IgG-seropositive patients;
- AQP4-IgG is negative in health people with age and sex matching and determined by cell-based assay;
- Female or male, age 14-80;
- Patients or authorized family members volunteered to participate in this study and signed informed consent.
Exclusion Criteria:
- Patients with coagulation disorders;
- Infection-related encephalitis;
- Immune-related encephalitis;
- A patient with severe mental illness who cannot cooperate clinically;
- A patient with severe jaundice.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
results of AQP4 -immunoglobulin G detection kit
Time Frame: through study completion, an average of 6 months
|
The Serum test results of participants using AQP4 -immunoglobulin G detection kit
|
through study completion, an average of 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- LS2019-004-02
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.